Chemotherapy Induced Neutropenia - Market Insights, Epidemiology and Market Forecast-2023 Market Report; Launched via MarketResearchReports.com
Market Research Reports, Inc. has announced the addition of “Chemotherapy Induced Neutropenia (CIN) - Market Insights, Epidemiology and Market Forecast-2023” research report to their website www.MarketResearchReports.com
Lewes, DE -- (SBWire) -- 03/28/2017 --Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and Market Forecast-2023 Report provides an overview of the disease and global market trends of the Chemotherapy Induced Neutropenia for the seven major markets i.e., United States, Europe (France, Germany, Italy, Spain, UK) and Japan, as well as rest of Europe (RoE) and rest of the world (RoW). The Report covers the therapeutics market revenue, treatment practice and Chemotherapy Induced Neutropenia (CIN) forecasted market share from 2017 to 2023 segmented by seven major markets. In addition, the report provides the historical and forecasted data of incident cases at risk of Chemotherapy Induced Neutropenia (CIN) in 10 cancer indications till 2023.
The report covers the number of patients for 10 cancer indications (i.e. Breast Cancer, Leukemia, Prostate Cancer, Lung Cancer, Cervical Cancer, Pancreatic Cancer, Colorectal Cancer, Ovarian Cancer, Hodgkin's disease and Non-Hodgkin Lymphoma), who are at risk of developing CIN as an adverse event of the chemotherapies of respective cancers.
Neupogen (Filgrastim), developed and marketed by Amgen is the first G-CSF approved for chemotherapy-induced neutropenia (CIN) in 1991. Its PEGylated formulation, Neulasta was later approved in 2002. Filgrastim i.e., Neupogen and PEGylated filgrastim (Neulasta) contribute to majority of the market size, of CIN. However, New Chemical Entities are expected to launch in the near future. According to Publisher, the Global Market size of CIN in 2016 was USD 3.67 Billion.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Spanning over 132 pages "Chemotherapy Induced Neutropenia (CIN) - Market Insights, Epidemiology and Market Forecast-2023" report covers Report Introduction, Global Market Size of CIN in 2016, Global Market Size of CIN in 2023, Appendix.
For more information Visit at: http://www.marketresearchreports.com/delveinsight/chemotherapy-induced-neutropenia-cin-market-insights-epidemiology-and-market-forecast
Find all Diseases Reports at: http://www.marketresearchreports.com/diseases
About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.
Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions
Media Relations Contact
Director - Operations
Market Research Reports, Inc.
View this press release online at: http://rwire.com/787790